Interview: Why Europe’s Biotech ‘Prime Time’ Is Now

VC Firm Sofinnova’s Chair Papiernik Speaks After New Fund Launch

 
• By Sten Stovall
  
Rocket
Sofinnova Plans 15 investments in the early-stage fund over three years • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business